291 related articles for article (PubMed ID: 10390452)
1. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.
Williamson LM; Lowe S; Love EM; Cohen H; Soldan K; McClelland DB; Skacel P; Barbara JA
BMJ; 1999 Jul; 319(7201):16-9. PubMed ID: 10390452
[TBL] [Abstract][Full Text] [Related]
2. Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005.
Stainsby D; Jones H; Wells AW; Gibson B; Cohen H;
Br J Haematol; 2008 Apr; 141(1):73-9. PubMed ID: 18324969
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of transfusion errors: putting data to use in the U.K.
Murphy MF
Dev Biol (Basel); 2005; 120():179-87. PubMed ID: 16050172
[TBL] [Abstract][Full Text] [Related]
4. The risk of transfusion to the wrong patient in Germany.
Caspari G; Alpen U; Greinacher A
Transfusion; 2002 Sep; 42(9):1238-9. PubMed ID: 12430685
[No Abstract] [Full Text] [Related]
5. SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents.
Bolton-Maggs PH
Transfus Med; 2016 Dec; 26(6):401-405. PubMed ID: 27995700
[TBL] [Abstract][Full Text] [Related]
6. Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review.
McQuilten ZK; Crighton G; Brunskill S; Morison JK; Richter TH; Waters N; Murphy MF; Wood EM
Transfus Med Rev; 2018 Jan; 32(1):6-15. PubMed ID: 28803752
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000.
Kuehnert MJ; Roth VR; Haley NR; Gregory KR; Elder KV; Schreiber GB; Arduino MJ; Holt SC; Carson LA; Banerjee SN; Jarvis WR
Transfusion; 2001 Dec; 41(12):1493-9. PubMed ID: 11778062
[TBL] [Abstract][Full Text] [Related]
8. Root cause analysis of non-infectious transfusion complications and the lessons learnt.
Karim F; Moiz B; Shamsuddin N; Naz S; Khurshid M
Transfus Apher Sci; 2014 Feb; 50(1):111-7. PubMed ID: 24239270
[TBL] [Abstract][Full Text] [Related]
9. 6 Years of shot reporting--its influence on UK blood safety.
Stainsby D; Williamson L; Jones H; Cohen H
Transfus Apher Sci; 2004 Oct; 31(2):123-31. PubMed ID: 15501416
[TBL] [Abstract][Full Text] [Related]
10. Reducing adverse events in blood transfusion.
Stainsby D; Russell J; Cohen H; Lilleyman J
Br J Haematol; 2005 Oct; 131(1):8-12. PubMed ID: 16173957
[TBL] [Abstract][Full Text] [Related]
11. Risks associated with the transfusion of various blood products in aortic valve replacement.
Bjursten H; Al-Rashidi F; Dardashti A; Brondén B; Algotsson L; Ederoth P
Ann Thorac Surg; 2013 Aug; 96(2):494-9. PubMed ID: 23816419
[TBL] [Abstract][Full Text] [Related]
12. Serious hazards of transfusion - conference report: celebration of 20 years of UK haemovigilance.
Bolton-Maggs PHB
Transfus Med; 2017 Dec; 27(6):393-400. PubMed ID: 29282809
[TBL] [Abstract][Full Text] [Related]
13. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.
Federici AB; Intini D; Lattuada A; Vanelli C; Arrigoni L; Sacchi E; Russo U
Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of 516 reports of reactions after the transfusion of labile blood products].
Frère MC; Rapaille A; Bouillenne C; Gérard C; Sondag D; Verhees A
Transfus Clin Biol; 2001 Aug; 8(4):333-42. PubMed ID: 11642025
[TBL] [Abstract][Full Text] [Related]
15. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
[TBL] [Abstract][Full Text] [Related]
16. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety.
Bolton-Maggs PH; Cohen H
Br J Haematol; 2013 Nov; 163(3):303-14. PubMed ID: 24032719
[TBL] [Abstract][Full Text] [Related]
17. Immediate transfusion reactions.
Climent-Peris C; Vélez-Rosario R
P R Health Sci J; 2001 Sep; 20(3):229-35. PubMed ID: 11776724
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
[TBL] [Abstract][Full Text] [Related]
19. The impact of uncross-matched blood transfusion on the need for massive transfusion and mortality: analysis of 5,166 uncross-matched units.
Inaba K; Teixeira PG; Shulman I; Nelson J; Lee J; Salim A; Brown C; Demetriades D; Rhee P
J Trauma; 2008 Dec; 65(6):1222-6. PubMed ID: 19077605
[TBL] [Abstract][Full Text] [Related]
20. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.
Berséus O; Boman K; Nessen SC; Westerberg LA
Transfusion; 2013 Jan; 53 Suppl 1():114S-123S. PubMed ID: 23301963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
